Month: March 2025

2025.03.26
Genomtec implements changes in organizational structure to accelerate M&A process

2025.03.12
The company will obtain approximately PLN 11 million from the issue to support the commercialization of projects

2025.02.12
Genomtec to issue shares to raise funds to support commercialization of projects

2025.01.28
Genomtec has filed a second patent application for the OncoSNAAT oncology project

2024.07.17
Summary of the most important events and achievements of the Genomtec S.A.

Archive

2025.03.26

Genomtec implements changes in organizational structure to accelerate M&A process

Genomtec SA has established two special purpose vehicles, GMT ID SA and GMT Genomics SA, in which it holds 100% of the shares. They will receive ...
Read
2025.03.12

The company will obtain approximately PLN 11 million from the issue to support the commercialization of projects

The shareholders of Genomtec SA at the Extraordinary General Meeting on 12 March 2025 voted on a resolution to increase the Company’s share ...
Read

Archive